Share on StockTwits

Shares of Sanofi SA (NYSE:SNY) have been given a consensus recommendation of “Hold” by the eleven ratings firms that are covering the stock, StockRatingsNetwork.com reports. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $55.00.

A number of analysts have recently weighed in on SNY shares. Analysts at Mainfirst upgraded shares of Sanofi SA to an “outperform” rating in a research note on Monday, July 28th. Analysts at Zacks reiterated a “neutral” rating on shares of Sanofi SA in a research note on Friday, June 20th. They now have a $57.00 price target on the stock.

Shares of Sanofi SA (NYSE:SNY) traded up 0.32% on Monday, hitting $53.36. The stock had a trading volume of 107,105 shares. Sanofi SA has a 52 week low of $46.95 and a 52 week high of $54.64. The stock’s 50-day moving average is $52.60 and its 200-day moving average is $51.92. The company has a market cap of $140.3 billion and a P/E ratio of 25.60.

Sanofi SA (NYSE:SNY) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.72 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.79 by $0.07. On average, analysts predict that Sanofi SA will post $3.50 earnings per share for the current fiscal year.

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.

Receive News & Ratings for Sanofi SA (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.